aldosterone has been researched along with glucose, (beta-d)-isomer in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Bienkowski, MJ; Petro, MA; Robinson, LJ | 1 |
| BIRO, L; GRABER, H; IVAN, E; SOMOGYI, G | 1 |
| Chen, CX; Gao, JP; Gu, WL; Lü, J; Wang, Y; Wu, Q | 1 |
| Chen, C; Gao, J; Gao, Y; Guo, J; Wang, H; Wu, R | 1 |
| Ahn, YB; Chung, S; Kim, ES; Kim, JW; Kim, MJ; Kim, SJ; Ko, SH; Lee, EM; Moon, SD; Shin, SJ; Yoo, YH | 1 |
| Kitzman, DW; Packer, M | 1 |
| Bell, M; Blake, L; Griffin, MD; Griffin, TP; Islam, MN; O'Shea, PM | 1 |
| Hara, K; Hatano, M; Hayashino, Y; Iida, S; Ikegami, Y; Isshiki, M; Ito, D; Kitazato, H; Noda, M; Saito, D; Sakuma, I; Satoh-Asahara, N; Shimada, A; Shiojima, I; Sumita, T; Takahashi, K | 1 |
| Fukuda, A; Hamada, K; Higashikawa, T; Iguchi, M; Ishigami, K; Ito, T; Izumida, T; Kanda, T; Kasamaki, Y; Kiyosawa, J; Kuroki, K; Maekawa, N; Mizuno, T; Mori, H; Morita, T; Nakahashi, T; Okuro, M; Saito, A; Sangen, R; Takagi, S; Takeshima, K; Usuda, D; Yamada, S | 1 |
1 review(s) available for aldosterone and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Obesity-Related Heart Failure With a Preserved Ejection Fraction: The Mechanistic Rationale for Combining Inhibitors of Aldosterone, Neprilysin, and Sodium-Glucose Cotransporter-2.
Topics: Aldosterone; Aminobutyrates; Angiotensin Receptor Antagonists; Benzhydryl Compounds; Biphenyl Compounds; Drug Combinations; Drug Therapy, Combination; Glucosides; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Neprilysin; Obesity; Plasma Volume; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Tetrazoles; Valsartan | 2018 |
1 trial(s) available for aldosterone and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration.
Topics: Aged; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypertension; Male; Middle Aged; Renin; Renin-Angiotensin System; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
7 other study(ies) available for aldosterone and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Inhibition of thromboxane A synthesis in U937 cells by glucocorticoids. Lack of evidence for lipocortin 1 as the second messenger.
Topics: Aldosterone; Annexins; Cell Differentiation; Cycloheximide; Dactinomycin; Estradiol; Gene Expression Regulation; Glucocorticoids; Glycoproteins; Humans; Kinetics; Lipopolysaccharides; Testosterone; Tetradecanoylphorbol Acetate; Thromboxane A2; Tumor Cells, Cultured; Zymosan | 1989 |
RELATIONSHIP BETWEEN ADRENAL GLAND AND PROPERDIN LEVEL.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Cortisone; Desoxycorticosterone; Pharmacology; Physiology; Prednisolone; Properdin; Rats; Research; Zymosan | 1964 |
Effects of polydatin on attenuating ventricular remodeling in isoproterenol-induced mouse and pressure-overload rat models.
Topics: Aldosterone; Angiotensin II; Animals; Aorta, Abdominal; Blood Pressure; Cardiovascular Agents; Collagen; Cyclic AMP; Drugs, Chinese Herbal; Endothelin-1; Fallopia japonica; Glucosides; Heart; Hypertrophy, Left Ventricular; Isoproterenol; Male; Mice; Myocytes, Cardiac; Organ Size; Phytotherapy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Stilbenes; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2010 |
Cardioprotective effect of polydatin on ventricular remodeling after myocardial infarction in coronary artery ligation rats.
Topics: Aldosterone; Animals; Antioxidants; Captopril; Collagen; Coronary Occlusion; Coronary Vessels; Endothelin-1; Glucosides; Heart Ventricles; Hydroxyproline; Hypertrophy; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Nitric Oxide; Phytotherapy; Plant Extracts; Polygonum; Rats, Sprague-Dawley; Renin-Angiotensin System; Stilbenes; Ventricular Remodeling | 2015 |
Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes.
Topics: Aldosterone; Animals; Benzhydryl Compounds; Chymosin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glucosides; Hyperglycemia; Kidney; Lipid Peroxidation; Male; Rats, Inbred OLETF; Renin-Angiotensin System; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
Effect of Sodium Glucose Co-Transporter-2 Inhibition on the Aldosterone/Renin Ratio in Type 2 Diabetes Mellitus.
Topics: Aged; Aldosterone; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Male; Middle Aged; Renin; Sodium-Glucose Transporter 2 Inhibitors; Triglycerides | 2019 |
Effects of tofogliflozin on adrenocorticotropic hormone, renin and aldosterone, and cortisol levels in elderly patients with diabetes mellitus: A retrospective study of a patient cohort.
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Humans; Hydrocortisone; Renin; Retrospective Studies | 2021 |